The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

Trump targets HHS in $810M appropriations clawback

Federal judge blocks Trump’s second attempt at imposing $100,000 fee for H1-B visas

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

HHS issues direct final rule to reduce reliance on animal testing

Clinical Roundup

Decipher prostate test predicts benefit from adding hormone therapy to radiation, phase III trial shows

City of Hope’s “plug-and-play” CAR T platform lets researchers update cells after infusion

Cedars-Sinai, UA Cancer Center study shows how missing pieces of Y chromosome drive cancer in men

Mount Sinai-led study identifies why some patients develop severe intestinal inflammation after CAR T therapy

Limiting sugar intake could reduce allogeneic hematopoietic cell transplant side effects

Lung cancers can use two different mechanisms to evade KRAS-inhibiting drug, MIT researchers find

In The Clinic

mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented

FreeGuest Editorial
Guest Editorial
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account